Clatterbridge Cancer Centre NHS Foundation Trust, UK; Department of Physics, University of Liverpool, UK.
Clatterbridge Cancer Centre NHS Foundation Trust, UK.
Radiography (Lond). 2024 Aug;30(5):1349-1354. doi: 10.1016/j.radi.2024.07.020. Epub 2024 Aug 3.
Shared decision-making (SDM) is on the NHS policy agenda, and the preferred model for preference-sensitive decisions. This study establishes baseline patient-perceived SDM in a radical head and neck cohort, and explores patients' views on SDM in a large, specialist trust.
An SDM questionnaire was distributed to all radical head and neck radiotherapy patients (N = 165), June-December 2023. This combined a well-validated instrument for measuring SDM from the patient perspective, SDM-Q-9, with additional questions exploring patient views. Thematic analysis was used to construct and interpret themes.
65/165 (39%) questionnaires were returned. SDM-Q-9 mean standardised score was 78.6 (SD 26.3). There was a moderate ceiling effect (26%). Scores were not sensitive to sex (p = 0.64) or age (ρ = 0.1). Higher levels of SDM were perceived by participants who stated SDM was very important (51/65, 79%) than somewhat or not at all important (82.4 vs. 62.7; p = 0.02; Cohen d = 0.75). Individuals who discussed their personal priorities with the clinician (46/65, 70.8%), were more likely to be very satisfied with their involvement in SDM (89.1% vs. 52.9%). Thematic analysis generated three themes: Control, Desire for Transparency and Understanding, and Doctor as the Expert.
Patient-perceived SDM levels are high for head and neck patients. Participants who value SDM also perceive higher levels of SDM. Patient satisfaction increases when individuals discuss their personal priorities. The modest response rate and self-selection bias affect the generalisability of the results. Only radiotherapy patients were included; those who chose alternative treatment may perceive different levels of SDM. The moderate ceiling effect may limit the use of SDM-Q-9 to measure impact of future interventions to improve SDM.
SDM-Q-9 should be combined with an objective, observer measure of SDM.
共同决策(SDM)是英国国家医疗服务体系(NHS)的政策议题,也是偏好敏感决策的首选模式。本研究在一个大型专业信托基金中,确定了头颈部根治性放疗患者的基线患者感知 SDM,并探讨了患者对 SDM 的看法。
2023 年 6 月至 12 月,向所有头颈部根治性放疗患者(N=165)发放 SDM 问卷。该问卷结合了从患者角度测量 SDM 的经过充分验证的工具 SDM-Q-9,以及探讨患者观点的其他问题。采用主题分析法构建和解释主题。
共收回 65/165(39%)份问卷。SDM-Q-9 平均标准化得分为 78.6(SD 26.3)。存在中等程度的天花板效应(26%)。性别(p=0.64)和年龄(ρ=0.1)对分数无影响。认为 SDM 非常重要的参与者(51/65,79%)比认为 SDM 有些重要或不重要的参与者(82.4 比 62.7;p=0.02;Cohen d=0.75)感知到更高水平的 SDM。与医生讨论个人优先事项的参与者(46/65,70.8%)更有可能对其参与 SDM 非常满意(89.1%比 52.9%)。主题分析生成了三个主题:控制、对透明度和理解的渴望、医生作为专家。
头颈部患者的患者感知 SDM 水平较高。重视 SDM 的参与者也感知到更高水平的 SDM。当个人讨论个人优先事项时,患者满意度会提高。适度的响应率和自我选择偏差影响结果的普遍性。仅纳入了接受放疗的患者;选择替代治疗的患者可能会感知到不同水平的 SDM。中等程度的天花板效应可能会限制 SDM-Q-9 用于衡量未来改善 SDM 的干预措施的影响。
SDM-Q-9 应与 SDM 的客观、观察者测量相结合。